title: Activation of carbamazepine-responsive T-cell clones with metabolically inert halogenated derivatives.
authors.forename: John
authors.initials: J
authors.lastname: Farrell
authors.forename: Maike
authors.initials: M
authors.lastname: Lichtenfels
authors.forename: Andrew
authors.initials: A
authors.lastname: Sullivan
authors.forename: Emma C
authors.initials: EC
authors.lastname: Elliott
authors.forename: Ana
authors.initials: A
authors.lastname: Alfirevic
authors.forename: Andrew V
authors.initials: AV
authors.lastname: Stachulski
authors.forename: Munir
authors.initials: M
authors.lastname: Pirmohamed
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Naisbitt
authors.forename: B Kevin
authors.initials: BK
authors.lastname: Park
mesh_terms: D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000276:immunology* / Q000378:metabolism*; D004342:Drug Hypersensitivity / Q000209:etiology / Q000276:immunology*; D006219:Halogens / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000209:etiology / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D006219:Halogens; D002220:Carbamazepine